NASDAQ · Financial Statements

SkinHealth Systems Inc. (SKIN) Revenue, Earnings & Financial Statements

$15.42 NASDAQ: SKIN Market Cap $100.46M

Data as of Nov 16, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

SkinHealth Systems Inc. most recently reported annual revenue of $301.0M, a net loss of $10.0M. Revenue grew at an average annual rate of 20.4% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

SkinHealth Systems Inc.: Revenue rose from $112.0M in 2018 to $301.0M in 2025, a change of +168.8% over 7 years; net profit was positive in 1 of 8 reported years; operating margin moved from 9.0% to -6.9%, a shift of -15.9 percentage points; the most recent year shows a net loss of $10.0M.

Income Statement — 8 Years (USD millions)

Metric20182019202020212022202320242025
Revenue$112.0M$167.0M$119.0M$260.0M$366.0M$398.0M$334.0M$301.0M
Operating Expenses$102.0M$153.0M$136.0M$300.0M$392.0M$529.0M$402.0M$322.0M
Operating Profit$10.0M$13.0M−$17.0M−$40.0M−$26.0M−$131.0M−$68.0M−$21.0M
Operating Margin9.0%8.1%-14.4%-15.3%-7.1%-32.9%-20.3%-6.9%
Other Income−$10.0M−$16.0M−$21.0M−$341.0M$71.0M$29.0M$38.0M$15.0M
Interest$10.0M$17.0M$21.0M$12.0M$13.0M$14.0M$10.0M$19.0M
Depreciation$11.0M$14.0M$15.0M$18.0M$23.0M$35.0M$34.0M$25.0M
Profit Before Tax$0−$3.0M−$38.0M−$381.0M$45.0M−$102.0M−$30.0M−$6.0M
Tax rate (%)3270.0%44.2%24.2%0.5%2.5%1.7%1.5%-60.3%
Net Profit$0−$2.0M−$29.0M−$379.0M$44.0M−$100.0M−$29.0M−$10.0M
EPS−$0.05−$1.02−$17.00−$73.40−$4.60−$15.20−$7.20−$3.20

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$97.0M$81.0M$91.0M$79.0M$83.0M$70.0M$78.0M$71.0M$82.0M$65.0M$72.0M$69.0M
Operating Expenses$115.0M$98.0M$113.0M$100.0M$91.0M$82.0M$81.0M$77.0M$82.0M$67.0M$69.0M$64.0M
Operating Profit−$18.0M−$17.0M−$22.0M−$22.0M−$7.0M−$12.0M−$3.0M−$6.0M$0−$2.0M$4.0M$5.0M
Operating Margin-19.0%-20.9%-24.4%-27.3%-8.6%-17.3%-3.5%-8.8%0.2%-2.8%5.0%7.2%
Interest$3.0M$3.0M$2.0M$2.0M$2.0M$2.0M$4.0M$6.0M$6.0M$6.0M$6.0M$6.0M
Profit Before Tax−$9.0M−$1.0M$0−$16.0M−$12.0M−$9.0M$19.0M−$11.0M−$5.0M−$7.0M−$1.0M$0
Tax rate (%)-6.8%49.3%233.8%-11.9%11.8%-9.7%-5.3%-3.6%-68.5%2.9%-82.7%-722.2%
Net Profit−$9.0M−$1.0M$0−$18.0M−$10.0M−$10.0M$20.0M−$11.0M−$8.0M−$7.0M−$3.0M−$1.0M
EPS−$1.46−$1.90−$2.00−$3.00−$1.66−$1.61$0.59−$1.80−$1.27−$1.00−$0.40−$0.14

Over the 8 years reported for SkinHealth Systems Inc., cash stood at $233.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.67 times.

Balance Sheet — 8 Years (USD millions)

Metric20182019202020212022202320242025
Total Assets—$226.0M$223.0M$1.2B$1.0B$929.0M$686.0M$500.0M
Current Assets—$54.0M$59.0M$1.0B$783.0M$698.0M$477.0M$310.0M
Cash—$7.0M$9.0M$902.0M$568.0M$523.0M$370.0M$233.0M
Inventory—$19.0M$23.0M$35.0M$110.0M$91.0M$69.0M$48.0M
Receivables—$24.0M$23.0M$51.0M$78.0M$55.0M$28.0M$23.0M
Fixed Assets—$11.0M$9.0M$31.0M$34.0M$26.0M$20.0M$14.0M
Capital Work in Progress$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$0$0
Other Assets—$99.0M$99.0M$124.0M$125.0M$126.0M$123.0M$127.0M
Total Liabilities—$228.0M$253.0M$917.0M$836.0M$870.0M$634.0M$439.0M
Current Liabilities—$38.0M$31.0M$76.0M$72.0M$115.0M$68.0M$186.0M
Borrowings$0$190.0M$217.0M$746.0M$752.0M$752.0M$568.0M$379.0M
Other Liabilities—$37.0M$36.0M$170.0M$84.0M$117.0M$66.0M$60.0M
Equity—$0$0$0$0$0$0$0
Reserves—−$1.0M−$30.0M$302.0M$167.0M$59.0M$52.0M$61.0M

For SkinHealth Systems Inc., operating cash flow was positive in 4 of 8 reported years; free cash flow in the latest year was $32.0M; free cash flow was positive in 3 of 8 years; financing activities used $2.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 8 Years (USD millions)

Metric20182019202020212022202320242025
Operating Cash Flow−$1.0M$2.0M−$12.0M−$28.0M−$107.0M$22.0M$16.0M$37.0M
Investing Cash Flow−$16.0M−$23.0M−$8.0M−$53.0M−$36.0M−$45.0M−$14.0M−$10.0M
Financing Cash Flow−$4.0M−$2.0M−$1.0M−$504.0M−$205.0M−$34.0M−$2.0M−$2.0M
Net Cash Flow$2.0M$4.0M$2.0M$892.0M−$334.0M−$45.0M−$153.0M−$137.0M
Free Cash Flow−$9.0M−$9.0M−$16.0M−$44.0M−$124.0M$9.0M$9.0M$32.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA7.74
FCF Yield17.22%
Quick Ratio2.22
Interest Coverage0.27
Return 1Y1154.62%
Return 3Y1073.38%
Return 5Y-36.74%

SkinHealth Systems Inc. (SKIN) financials — frequently asked questions

What is SkinHealth Systems Inc.'s annual revenue?

SkinHealth Systems Inc. (SKIN) reported annual revenue of $301.0M in its most recent fiscal year.

What is SkinHealth Systems Inc.'s net profit?

SkinHealth Systems Inc. (SKIN) reported a net loss of $10.0M in its most recent fiscal year.

What is SKIN EV/EBITDA?

SkinHealth Systems Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 7.74.

Revenue and earnings of other Medical - Specialties stocks

ALC revenue $10.4BSTE revenue $5.9BMLAB revenue $249.0MQDEL revenue $2.7BMOBI stockSI stockMASS revenue $56.0MANIK revenue $113.0MAPYX revenue $53.0MNYXH revenue $10.0MAll Healthcare stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
SKIN Overview SKIN Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.